4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-21-082068
Options or other derivatives
- Chief Medical Officer acquired 39,380 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | 2021-06-14 | Grant or award · Restricted Stock Units | +39,380 | 39,380 | D: show line 1 in the form |
Loading xslF345X03/tm2119923-3_4seq1.xml…